MEC Plus Full List View

MEC Plus

Recent Advances in Colorectal Cancer
Recent Advances in Colorectal Cancer
Heinz-Josef Lenz, MD, FACP
Updates in the Management of Pancreatic Cancer
Updates in the Management of Pancreatic Cancer
Vincent Chung, MD, FACP
Advances in Cellular Therapies for Cancer
Advances in Cellular Therapies for Cancer
Mohamed Abou-el-Enein, MD, PhD, MSPH
Advances in Non-PD(L)1 Immunotherapies in Solid Tumors
Advances in Non-PD(L)1 Immunotherapies in Solid Tumors
Miguel Villalona-Calero, MD
Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer
Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer
David Gandara, MD
Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP
Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP
S. Percy Ivy, MD
Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?
Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?
Paul Frankel, PhD
Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory
Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory
Timothy Synold, PharmD
Mesothelioma and Thymoma – Limited and Advanced Stage
Mesothelioma and Thymoma – Limited and Advanced Stage
Shiruyeh Schokrpur, MD, PhD
Small Cell Lung Cancer
Small Cell Lung Cancer
Millie Das, MD
Other Immunotherapy Targets & Agents- Advanced NSCLC
Other Immunotherapy Targets & Agents- Advanced NSCLC
Joel Neal, MD, PhD
PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC
PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC
David Gandara, MD
EGFR Mutated Lung Cancer - Advanced Stage
EGFR Mutated Lung Cancer - Advanced Stage
Collin Blakely, MD, PhD
ALK, ROS1, and BRAF Positive Lung Cancer
ALK, ROS1, and BRAF Positive Lung Cancer
Mohana Roy, MD
Tumor Biology, Pathology, Novel Diagnostics
Tumor Biology, Pathology, Novel Diagnostics
Tianhong “Tina” Li, MD, PhD
Palliative Care Approaches in Lung Cancer
Palliative Care Approaches in Lung Cancer
Kavitha Ramchandran, MD
Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy
Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy
Surbhi Singhal, MD
Stage III NSCLC – Surgical/Combined Modality
Stage III NSCLC – Surgical/Combined Modality
Johannes R. Kratz, MD
Locally Advanced NSCLC- Radiation Therapy
Locally Advanced NSCLC- Radiation Therapy
Lucas Vitzthum, MD, MAS
Radiation in Early-Stage NSCLC
Radiation in Early-Stage NSCLC
Megan Daly, MD
Adjuvant/Neo-adjuvant Systemic Therapy
Adjuvant/Neo-adjuvant Systemic Therapy
Heather Wakelee, MD, FASCO
Surgery for Early-Stage NSCLC
Surgery for Early-Stage NSCLC
Johannes R. Kratz, MD
Pulmonary – From Diagnostics to Therapeutics
Pulmonary – From Diagnostics to Therapeutics
Nicholas Stollenwerk, MD
Lung Cancer Screening / Tobacco Control
Lung Cancer Screening / Tobacco Control
Natalie Lui, MD, MAS
2024 Small Cell Lung Cancer
2024 Small Cell Lung Cancer
Diane Tseng, MD
2024 Metastatic Non-Small Cell Lung Cancer
2024 Metastatic Non-Small Cell Lung Cancer
Rafael Santana-Davila, MD
2024 Locally Advanced NSCLC
Neoadjuvant/Adjuvant/Multi-Modality
2024 Locally Advanced NSCLC Neoadjuvant/Adjuvant/Multi-Modality
Sylvia Lee, MD
Triple Negative Breast Cancer Updates
Triple Negative Breast Cancer Updates
Sara A. Hurvitz, MD
HER2-Positive Breast Cancer Updates
HER2-Positive Breast Cancer Updates
Bora Lim, MD
Lymphoma and CLL 2024 Updates
Lymphoma and CLL 2024 Updates
Maxwell M. Krem, MD, PhD